Axcelead DDP and Superluminal Announce the Intent to Collaborate on Drug Discovery Targeting Specific Molecular Mechanisms, continuing a productive relationship
Kanagawa, Japan and Boston, MA, USA – Jun …
Dr. Fukui (Senior Director, Safety BU) to Deliver an Oral Presentation at the 52nd Annual Workshop of the Japanese Society of Toxicology
Senior Director and Senior Consultant Dr. Fukui from …
Researcher Yoshida from Safety BU to Present a Poster at the 10th Annual Meeting of the Japan Nucleic Acid Therapeutics Society
Our researcher, Ikuma Yoshida from the Safety Business …
LOTTE BIOLOGICS, Axcelead Drug Discovery Partners, Inc., and Kanaph Therapeutics Inc. Sign 3-Way MOU to Develop ADC Toolbox
– Exploring expansion of ADC services through synergy …
Presentation on Prediction Model for Brain Concentration-Time Profiles of Compounds by Dr. Handa (Digital Unit) at the Structure-Activity Forum 2025
Dr. Handa from the Digital Unit will present …
BIO International Convention 2025
Boston, MA
Comparison of anti-obese effects on GLP-1 analogue peptides, Semaglutide, Tirzepatide and Retatrutide using MC4R deficient obesity model mice
ECO 2025（32nd European Congress on Obesity）
The results of joint research with Luxna Biotec, Inc published in “Nucleic Acid Therapeutics”
Hepatotoxicity Reduction Profiles of Antisense Oligonucleotides Containing Amido-Bridged …